Journal articleObstet Gynecol Surv · July 1, 2026
IMPORTANCE: Preterm premature rupture of membranes (PPROM) presents significant challenges in obstetric care, particularly due to its association with both maternal and neonatal morbidity. Management becomes even more complex when PPROM occurs in the conte ...
Full textLink to itemCite
Journal articleJ Immunol Res · 2025
Problem: Antiretroviral therapy (ART) during pregnancy is essential to prevent vertical HIV transmission and preserve the health of the mother and child. However, ART in pregnancy has been associated with adverse birth outcomes linked to poor placental dev ...
Full textLink to itemCite
Journal articleNorth Carolina Medical Journal · July 5, 2023
BackgroundCardiac disease is a leading cause of severe maternal morbidity (SMM). We sought to estimate the effects of race and rural-urban status on cardia ...
Full textCite
Journal articleTrop Med Infect Dis · November 26, 2021
Obstetrician-gynecologists in the United States have little clinical experience with the epidemiology, pathophysiology, diagnosis, and treatment of Chagas disease. The number of US parturients born in Central and South America has continued to increase ove ...
Full textLink to itemCite
Journal articleClin Infect Dis · September 15, 2021
BACKGROUND: To evaluate the frequency and associated characteristics of chronic comorbid conditions and obstetrical complications among pregnant women with human immunodeficiency virus (HIV) and receiving antiretroviral therapy (ART) in comparison to those ...
Full textLink to itemCite
Journal articleTher Adv Infect Dis · 2021
Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a public health concern, mainly among countries in South and Central America. However, despite the large number of immigrants from endemic countries living in the USA, awareness of CD is po ...
Full textLink to itemCite
Journal articleMedEdPORTAL · October 29, 2020
INTRODUCTION: Learning to elicit a sexual history and counsel patients on sexual pain aligns with the Association of Professors of Gynecology and Obstetrics clerkship objectives. This topic can be challenging to cover due to lack of exposure in clinical en ...
Full textLink to itemCite
Journal articleObstet Gynecol · May 2018
OBJECTIVE: To describe patterns and factors associated with mode of delivery among pregnant women with human immunodeficiency virus (HIV) infection in the United States in relation to evolving HIV-in-pregnancy guidelines. METHODS: We conducted an analysis ...
Full textLink to itemCite
Journal articleObstet Gynecol Surv · February 2018
IMPORTANCE: Intrahepatic cholestasis of pregnancy (ICP) complicates approximately 0.2% to 2% of pregnancies and can lead to increased fetal risks in pregnancy. OBJECTIVE: This review aims to increase the knowledge of women's health care providers regarding ...
Full textLink to itemCite
Journal articleJ Acquir Immune Defic Syndr · September 1, 2016
OBJECTIVE: To investigate complications of cesarean section in a cohort of HIV-infected pregnant women. METHODS: IMPAACT P1025 is a prospective cohort study of HIV-1-infected women and infants, enrolled 2002-2013, at clinical sites in the United States and ...
Full textLink to itemCite
Journal articleAm J Obstet Gynecol · March 2016
BACKGROUND: Minimizing time to HIV viral suppression is critical in pregnancy. Integrase strand transfer inhibitors (INSTIs), like raltegravir, are known to rapidly suppress plasma HIV RNA in nonpregnant adults. There are limited data in pregnant women. OB ...
Full textLink to itemCite
Journal articleJ Acquir Immune Defic Syndr · February 1, 2016
OBJECTIVES: Depot medroxyprogesterone acetate (DMPA) was associated with increased HIV transmission and accelerated disease progression in untreated women. The potential underlying mechanisms include immune modulation. We evaluated the effect of a single D ...
Full textLink to itemCite
Journal articleAntimicrob Agents Chemother · April 2015
We conducted an open-label, steady-state pharmacokinetic (PK) study of drug-drug interactions between depot medroxyprogesterone acetate (DMPA) and twice-daily lopinavir (LPV) plus low-dose ritonavir (RTV) (LPV/r) among 24 HIV-infected women and compared th ...
Full textLink to itemCite
Journal articleAnn Intern Med · January 20, 2015
BACKGROUND: A high delivery maternal plasma HIV-1 RNA level (viral load [VL]) is a risk factor for mother-to-child transmission and poor maternal health. OBJECTIVE: To identify factors associated with detectable VL at delivery despite initiation of highly ...
Full textLink to itemCite
Journal articleCouncil on Resident Education in Obstetrics & Gynecology (CREOG) and Association of Professors of Gynecology & Obstetrics (APGO) Annual Meeting: Signs of Progress in Women's Health Education. Atlanta, GA · 2014
We are pleased to inform you that your abstract entitled, #314 Evaluating a Preceptor-Based Clerkship Model, has been accepted for a poster presentation at the 2014 CREOG and APGO Annual Meeting, which will be held at the Hyatt Regency Atlanta, February 26 ...
Cite
Journal articleTopics in Antiviral Medicine · 2014
Background: Little is known about use of depot medroxyprogesterone acetate (MPA) with boosted-protease inhibitors (PIs), a commonly used antiretroviral treatment regimen. Interactions with boosted PIs could lead to changes in efficacy or toxicity of any of ...
Link to itemCite
Journal articleJ Acquir Immune Defic Syndr · December 1, 2013
OBJECTIVE: To determine whether maternal use of tenofovir disoproxil fumarate for treatment of HIV in pregnancy predicts fetal and infant growth. METHODS: The study population included HIV-uninfected live-born singleton infants of mothers enrolled in the I ...
Full textLink to itemCite
Journal articleCouncil on Resident Education in Obstetrics & Gynecology (CREOG) and Association of Professors of Gynecology & Obstetrics (APGO) Annual Meeting: Extending Your Reach in Women’s Health Education: Up, Out, Across, and Around. Phoenix, AZ · 2013
Objective: To assess the utility of a Centering model of obstetric care for teaching in a longitudinal integrated clerkship year and compare with traditional students’ experiences. Background: In 2010, Duke University School of Medicine offered a longitudi ...
Link to itemCite
Journal article19th International AIDS Conference, Washington, DC · 2012
Background: The use of Tenofovir Disoproxil Fumarate (TDF) for the treatment of HIV in pregnancy is increasing. The effects of exposure to TDF in utero on fetal and infant growth are unclear. Methods: The study population included live born singleton infan ...
Link to itemCite
Journal articleObstet Gynecol · August 2010
OBJECTIVE: To estimate risk of infant respiratory morbidity associated with cesarean delivery before labor and ruptured membranes among HIV-1-infected women. METHODS: In a prospective cohort study of HIV-1-infected women and their infants, mode of delivery ...
Full textLink to itemCite
Journal articleJ Infect Dis · April 1, 2010
BACKGROUND: Conflicting results have been reported among studies of protease inhibitor (PI) use during pregnancy and preterm birth. Uncontrolled confounding by indication may explain some of the differences among studies. METHODS: In total, 777 human immun ...
Full textOpen AccessLink to itemCite
Journal articleHIV Clin Trials · 2008
BACKGROUND: The effects of gestational nucleoside reverse transcriptase inhibitors (NRTIs) on mitochondrial DNA (mtDNA) are controversial. The effects of mtDNA depletion on mitochondrial function have not been assessed. METHOD: In peripheral blood mononucl ...
Full textLink to itemCite
Journal articleAntivir Ther · 2008
BACKGROUND: To investigate the effect of exposure to protease inhibitor (PI) therapy in utero on cord blood lipids in infants born to mothers enrolled in AIDS Clinical Trials Group protocol 5084, a prospective, multicentre, observational study of antiretro ...
Link to itemCite
Journal articleObstet Gynecol · August 2007
OBJECTIVE: To evaluate the effect of protease inhibitors on lipid and lactate levels and gastrointestinal symptoms in pregnancy. METHODS: Acquired Immunodeficiency Syndrome (AIDS) Clinical Trials Group (ACTG) A5084 was an observational cohort study of huma ...
Full textLink to itemCite
Journal articleAm J Obstet Gynecol · April 2007
OBJECTIVE: The objective of the study was to determine whether protease inhibitors increase glucose intolerance and insulin resistance in pregnancy. STUDY DESIGN: In this multicenter, prospective, observational study, 149 human immunodeficiency virus-1-inf ...
Full textLink to itemCite
Journal articleEnviron Mol Mutagen · 2007
Zidovudine-based antiretroviral therapies (ARTs) for treatment of HIV-infected pregnant women have markedly reduced mother-to-child transmission of the human immunodeficiency virus (HIV-1) from approximately 25% to <1%. However, zidovudine (ZDV; AZT), a nu ...
Full textLink to itemCite
Journal articleInternational Aids Society Meeting. Toronto, Canada · 2006
Poster - International Aids Society Meeting. Toronto Canada August 15, 2006. ...
Link to itemCite
Journal articleJ Reprod Med · October 2004
BACKGROUND: The B-Lynch uterine suture brace has been used for the surgical treatment of postpartum hemorrhage. To date, no complications of this procedure have been reported. We describe B-Lynch suture erosion through the uterine wall identified at a 6-we ...
Link to itemCite
Journal articleCurr Womens Health Rep · August 2002
In the US, transmission of HIV infection from pregnant women to their infants is now highly preventable. HIV infection is sufficiently common to justify extension of HIV screening to all pregnant women. Once HIV infection is identified, the degree of immun ...
Link to itemCite
Journal articleJ Infect Dis · July 15, 2002
Pediatric AIDS Clinical Trials Group protocol 316 was an international, multicenter, placebo-controlled trial comparing single-dose oral nevirapine (200 mg to mother and 2 mg/kg to infant) with placebo in human immunodeficiency virus (HIV)-infected pregnan ...
Full textLink to itemCite
Journal articleJ Ultrasound Med · October 2001
OBJECTIVE: This study compares transperineal and endovaginal ultrasonography of the gravid cervix to evaluate image quality and assess for a systematic difference in cervical lengths measured by the 2 techniques. METHODS: Transperineal and endovaginal ultr ...
Full textLink to itemCite
Journal articleJ Clin Microbiol · December 1999
We examined the patterns of strain relatedness among pathogenic yeasts from within and among groups of women to determine whether there were significant associations between genotype and host condition or body site. A total of 80 yeast strains were isolate ...
Full textLink to itemCite
Journal articleJ Infect Dis · November 1999
Didanosine (ddI) pharmacokinetics in antepartum and postpartum human immunodeficiency virus (HIV)-infected women and their neonates were studied. HIV-infected pregnant women received an intravenous (iv) ddI infusion (1.6 mg/kg/h) or an oral dose (200 mg bi ...
Full textLink to itemCite
Journal articleAnn Med · August 1998
In the US over one million persons are currently infected with the HIV, over half a million have had AIDS, and over 300,000 have died from AIDS. Worldwide, it is estimated that more than 17 million people are currently infected with HIV, and over 1,200,000 ...
Full textLink to itemCite
Journal articlePrenatal and Neonatal Medicine · August 1, 1998
Objectives: To evaluate the safety and efficacy of saline alone for the intrapartum management of insulin-requiring diabetic patients and their infants. Methods: This was a retrospective evaluation of 77 insulin-requiring diabetic patients, over a 12-year ...
Cite
Journal articlePrenat Diagn · February 1998
A mosaic chromosome complement, 46,XY/47,XY,+r(15), was detected at prenatal diagnosis. Family studies showed the mother and one of her two children to have a bisatellited supernumerary marker chromosome (SMC) in all lymphocytes examined. The maternal gran ...
Full textLink to itemCite
Journal articleInfect Dis Obstet Gynecol · 1998
OBJECTIVE: To study maternal and neonatal effects of combination nucleoside analog therapy administered to human immunodeficiency virus (HIV)-infected pregnant women for maternal indications. METHODS: A multicenter, prospective observational study was unde ...
Full textLink to itemCite
Journal articleInfectious Diseases in Obstetrics and Gynecology · 1998
Objective: To study maternal and neonatal effects of combination nucleoside analog therapy administered to human immunodeficiency virus (HIV)- infected pregnant women for maternal indications. Methods: A multicenter, prospective observational study was und ...
Full textCite
Journal articleSouth Med J · September 1997
The objectives of our study were to determine the prevalence of cervical intraepithelial neoplasia (CIN) in a southeastern human immunodeficiency virus (HIV)-positive population relative to an HIV-negative control group and to compare these findings with p ...
Full textLink to itemCite
Journal articleObstet Gynecol · May 1997
OBJECTIVE: To review the epidemiology and clinical course of hepatitis C virus (HCV) infection, to examine current data on the vertical transmission of HCV to neonates, and to develop recommendations for intrapartum and postpartum follow-up of neonates bor ...
Full textLink to itemCite
Journal articleMedscape Womens Health · January 1997
The fact that zidovudine therapy can prevent perinatal transmission of HIV infection strongly supports the need to screen for HIV during pregnancy. Controversy continues to revolve around which testing strategy offers the benefits of zidovudine to the grea ...
Link to itemCite
Journal articleRadiology · June 1996
PURPOSE: To assess the frequency of fetal gallbladder visualization through gestation and to determine the prognostic importance of nonvisualization. MATERIALS AND METHODS: Demonstration of the gallbladder was prospectively attempted in 578 consecutive sec ...
Full textLink to itemCite
Journal articleInt J Obstet Anesth · January 1995
Emergent attainment of uterine relaxation is an occasional need in obstetric practice. Various agents, from amyl nitrate through volatile anesthetics have been used to relax the uterus, with varying degrees of success and side-effects. Recent publications ...
Full textLink to itemCite
Journal articleInt J Gynecol Pathol · October 1992
A 39-year-old woman undergoing immunosuppressive therapy following kidney transplantation for systemic lupus erythematosus presented with a uterine adenomatoid tumor that diffusely infiltrated the entire myometrium and contained a serosal papillary cystic ...
Full textLink to itemCite
Journal articleN Engl J Med · March 26, 1992
BACKGROUND AND METHODS: The expanding indications for zidovudine treatment make it important to elucidate the safety and toxicity of this drug for pregnant women and their fetuses. We asked pediatricians and obstetricians at the AIDS (acquired immunodefici ...
Full textLink to itemCite
Journal articleAm J Obstet Gynecol · June 1990
Fetal distress is a widely used but poorly defined term. This confusion of definition compounds the difficulty of making an accurate diagnosis and initiating appropriate treatment. The fetus reacts at the onset of asphyxia with a remarkable series of respo ...
Full textLink to itemCite
Journal articlePsychosom Med · 1985
The obese (C57BL/6J ob/ob) mouse is a commonly used animal model of non-insulin-dependent diabetes mellitus. It has recently been demonstrated that this mouse is not consistently hyperglycemic, however, unless it is subjected to environmental stress. In th ...
Full textLink to itemCite
Journal articleDiabetes · July 1984
The genetically obese mouse (C57BL/6J ob/ob) is a commonly used model of non-insulin-dependent diabetes mellitus. However, our studies demonstrate that, while the animal is significantly hyperinsulinemic, it in fact does not show consistent hyperglycemia i ...
Full textLink to itemCite